Skip to content

Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in Patients With Pulmonary Hypertension

Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in Patients With Pulmonary Hypertension: A Comparative Experimental Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07648524
Enrollment
42
Registered
2026-06-15
Start date
2026-06-13
Completion date
2026-09-13
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Hypertension Due to Lung Disease (Disorder)

Keywords

Pulmonary Hypertension Cardiopulmonary Rehabilitation Inspiratory Muscle Training Exercise Training Functional Capacity Pulmonary Function

Brief summary

This study aims to investigate the effect of cardiopulmonary rehabilitation on cardiorespiratory parameters and functional capacity in patients with pulmonary hypertension.

Detailed description

Pulmonary hypertension is a progressive disease associated with reduced exercise capacity, respiratory muscle weakness, and impaired quality of life. Exercise training and respiratory muscle training have been shown to improve physical performance and quality of life in patients with pulmonary hypertension. forty-two medically stable patients with Group III pulmonary hypertension due to lung diseases (obstructive and restrictive) will participate in this comparative experimental study. Participants will receive cardiopulmonary rehabilitation consisting of moderate-intensity interval aerobic training and inspiratory muscle training in addition to routine medical treatment. Outcome measures will include echocardiographic parameters, pulmonary function, six-minute walk distance, estimated VO2max, dyspnea severity, and quality of life. The study aims to evaluate the influence of cardiopulmonary rehabilitation on cardiorespiratory adaptation in patients with pulmonary hypertension.

Interventions

BEHAVIORALcardiopulmonary rehabilitation in the form of moderate-intensity interval aerobic training

Training will be conducted on a treadmill three times weekly for 12 weeks. Exercise intensity will progress from 30-40% to 60-70% of target heart rate. Each session will last 30 minutes and include warm-up and cool-down periods.

DEVICEInspiratory Muscle Training

inspiratory muscle training will be performed using a Threshold Inspiratory Muscle Trainer (Philips Respironics). Training intensity will correspond to moderate-to-severe effort (3-5 on the Modified Borg Scale).

OTHERMedical treatment

medication

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

\- a)Medically stable pulmonary hypertension patients who were under optimized medical therapy. b)Pulmonary artery pressure ≥ 25 mmHg confirmed by RT side heart catheterization. c)Forty two male patients with group 3 pulmonary hypertension (Chest cause) include Obstructive lung disease ( COPD and sleep apnea ) and restrictive lung disease (ILD). d)The patients' ages will range from 45 to 65 years old. e)BMI (25 - 34.9) kg/m2. f)World Health Organization (WHO) classification of functional classes II to III ( class II are patients with pulmonary hypertension who have a mild limitation of physical activity )(class III are patients with pulmonary hypertension who have a marked limitation of physical activity

Exclusion criteria

* g)Uncontrolled systemic HTN. h)Other types of pulmonary hypertension.. i)Smoker j)Any condition of kidney failure. k)Neurological or musculoskeletal conditions that interfere with gait l)Impaired vision and/or hearing. m)Patients who are unable to follow verbal instructions. n)acute exacerbation condition. o)unstable angina, serious cardiac dysrhythmias on resting ECG.

Design outcomes

Primary

MeasureTime frameDescription
6-minute walk distance12 weekstotal distance walked in 6 minutes
Maximal Oxygen Consumption12weeksEstimated VO2max
spirometry12weeksFEV1, FVC, FEV1/FVC, MVV

Secondary

MeasureTime frameDescription
Dyspnea Severity12weeksModified Borg Scale
change Pulmonary Artery Pressure12weekspulmonary artery pressure estimated by ECHO
change of total score of SF-12 Questionnaire) Quality of Life12weeksmore increase scores more increase quality of life

Countries

Egypt

Contacts

CONTACTRana Essam El Din Abd Elbar, Assistant lecturer
rana.essam@acu.edu.eg01013981766
STUDY_CHAIRNESREEN GHAREEB MOHAMED EL-NAHAS, Prof PT

faculty of P.T. Cairo University

STUDY_CHAIRHEBA AHMED ALI ABDEEN, Prof

faculty of P.T. Cairo University

STUDY_CHAIRHEND ABD EL-MONAEM ABD EL-MONAEM, Lecturer of physical therapy

faculty of P.T. Cairo University

STUDY_CHAIRREEM IBRAHIM EL KORASHY, prof of pulmonology

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026